Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

KRMD

KORU Medical Systems (KRMD)

KORU Medical Systems Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:KRMD
日付受信時刻ニュースソース見出しコード企業名
2024/06/0522 : 00Business WireSimplifying Subcutaneous Drug Administration: SCHOTT Pharma and KORU Medical Systems Announce Collaboration to Advance Large Volume Subcutaneous InfusionNASDAQ:KRMDKORU Medical Systems Inc
2024/06/0505 : 03Business WireKORU Medical Systems Announces a New Feasibility Study with a Commercialized Oncology BiologicNASDAQ:KRMDKORU Medical Systems Inc
2024/06/0406 : 19Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KRMDKORU Medical Systems Inc
2024/05/2320 : 00Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:KRMDKORU Medical Systems Inc
2024/05/1506 : 06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KRMDKORU Medical Systems Inc
2024/05/1505 : 05Business WireKORU Medical Systems Signs Supply Agreement for a Phase III Clinical Trial for a Novel Endocrinological BiologicNASDAQ:KRMDKORU Medical Systems Inc
2024/05/0205 : 05Business WireKORU Medical Systems, Inc. Announces 2024 First Quarter Financial Results Delivering Double-Digit Revenue GrowthNASDAQ:KRMDKORU Medical Systems Inc
2024/04/1720 : 00Business WireKORU Medical Systems to Report First Quarter 2024 Financial Results on May 1, 2024NASDAQ:KRMDKORU Medical Systems Inc
2024/04/1205 : 05Business WireKORU Medical Systems Announces Successful Appeal in EU Notified Body ReviewNASDAQ:KRMDKORU Medical Systems Inc
2024/03/1906 : 24Business WireKORU Medical Systems to Present Data Demonstrating 97% Adherence on Its Freedom Infusion System for Large Volume Subcutaneous Administration at NHIA 2024 ConferenceNASDAQ:KRMDKORU Medical Systems Inc
2024/03/1405 : 05Business WireKORU Medical Systems, Inc. Announces 2023 Fourth Quarter, Full Year Financial Results, and 2024 GuidanceNASDAQ:KRMDKORU Medical Systems Inc
2024/03/1205 : 05Business WireKORU Medical Systems Announces a Feasibility Study to Enter Ambulatory Infusion Settings with a Commercialized BiologicNASDAQ:KRMDKORU Medical Systems Inc
2024/03/0621 : 00Business WireKORU Medical Systems Signs a Clinical Supply Agreement for Phase 3 Trial with Leading Pharma Partner Using Custom Device for a Novel Subcutaneous ImmunoglobulinNASDAQ:KRMDKORU Medical Systems Inc
2024/02/2121 : 00Business WireKORU Medical Systems to Report Fourth Quarter and Full Year 2023 Financial Results on March 13, 2024NASDAQ:KRMDKORU Medical Systems Inc
2023/11/2921 : 00Business WireKORU Medical Systems to Participate in Piper Sandler’s 35th Annual Healthcare ConferenceNASDAQ:KRMDKORU Medical Systems Inc
2023/11/2822 : 00Business WireKORU Medical Systems, Inc. to Host Investor Day on December 5, 2023NASDAQ:KRMDKORU Medical Systems Inc
2023/11/0906 : 10Business WireKORU Medical Systems, Inc. Announces Development Agreement for Next-generation Subcutaneous Immunoglobulin Infusion SystemNASDAQ:KRMDKORU Medical Systems Inc
2023/11/0906 : 08Business WireKORU Medical Systems, Inc. Appoints Ken Miller as Chief Commercial OfficerNASDAQ:KRMDKORU Medical Systems Inc
2023/11/0906 : 05Business WireKORU Medical Systems, Inc. Announces 2023 Third Quarter Financial Results and Updates Full Year 2023 OutlookNASDAQ:KRMDKORU Medical Systems Inc
2023/11/0806 : 05Business WireKORU Medical Systems, Inc. Receives FDA 510(k) Clearance for FREEDOM60® Infusion System With Hizentra® 50 ML Prefilled SyringesNASDAQ:KRMDKORU Medical Systems Inc
2023/11/0305 : 05Business WireKORU Medical Systems to Participate in Upcoming Investor ConferencesNASDAQ:KRMDKORU Medical Systems Inc
2023/10/2605 : 05Business WireKORU Medical Systems to Report Third Quarter Financial Results on November 8, 2023NASDAQ:KRMDKORU Medical Systems Inc
2023/10/0520 : 05Business WireKORU Medical Systems to Present Two Abstracts at the Immunoglobulin National Society 2023 National ConferenceNASDAQ:KRMDKORU Medical Systems Inc
2023/10/0505 : 05Business WireKORU Medical Systems, Inc. Announces Appointment of Edward Wholihan to Its Board of DirectorsNASDAQ:KRMDKORU Medical Systems Inc
2023/09/1521 : 05Business WireKORU Medical Systems to Participate in the Gilmartin Group Emerging Growth Company ShowcaseNASDAQ:KRMDKORU Medical Systems Inc
2023/08/1005 : 05Business WireKORU Medical Systems, Inc. Announces 2023 Second Quarter Financial Results and Updates Full Year 2023 OutlookNASDAQ:KRMDKORU Medical Systems Inc
2023/08/0905 : 05Business WireKORU Medical Systems to Participate in the Genuity 43rd Annual Growth ConferenceNASDAQ:KRMDKORU Medical Systems Inc
2023/08/0306 : 15Business WireKORU Medical Systems, Inc. Announces Preliminary Second Quarter 2023 Revenues and Provides Business, Outlook and Executive UpdatesNASDAQ:KRMDKORU Medical Systems Inc
2023/08/0105 : 05Business WireKORU Medical Systems to Report Second Quarter Financial Results on August 9, 2023NASDAQ:KRMDKORU Medical Systems Inc
2023/07/2805 : 05Business WireKORU Medical Systems Announces Novel Therapies Collaboration for Late-Stage Endocrinological BiologicNASDAQ:KRMDKORU Medical Systems Inc
 Showing the most relevant articles for your search:NASDAQ:KRMD

最近閲覧した銘柄